Standard Package Regulatory Data Pharmacopoeias Production Site ACEBUTOLOL HCl (34381-68-5) - & AMANTADINE HCl (665-66-7) Antiviral - Antiparkinsonian AMANTADINE SULPHATE (31377-23-8) Antiviral - Antiparkinsonian DAC 2003 AMLODIPINE BESILATE (111470-99-6) Antianginal -, JDMF ARTICAINE or CARTICAINE (23964-57-0) Local Anesthetic - BENECHIM BISOPROLOL FUMARATE (104344-23-2), JDMF, JP15 BUPIVACAINE HYDROCHLORIDE (73360-54-0) 25 kg CARBOCYSTEINE (638-23-3) Mucolytic JDMF JP 15 CARVEDILOL (72956-09-3), JDMF CELIPROLOL HCl (57470-78-7) JDMF & CHOLINE FENOFIBRATE (856676-23-8) Antihyperlipidemic Fiber drum FENOFIBRATE (49562-28-9) Antihyperlipidemic Fiber drum 1 Product List
Standard Package Regulatory Data Pharmacopoeias Production Site LANSOPRAZOLE (103577-45-3) Antiulcerative,, JDMF LIDOCAINE BASE (137-58-06), JDMF, LIDOCAINE HCl (6108-05-0) 35 Kg, JDMF, MAGNESIUM LACTATE DIHYDRATE (18917-93-6) Magnesium Supplement MEBEVERINE HYDROCHLORIDE (2753-45-9) Antispasmodic 30 Kg BP 2010 BENECHIM & MEPIVACAINE HYDROCHLORIDE (1722-62-9) 20 Kg METOPROLOL SUCCINATE (98418-47-4) METOPROLOL TARTRATE (56392-17-7), JDMF MOLSIDOMINE (25717-80-0) Vasodilator BENECHIM N-ACETYLCYSTEINE (616-91-1) Mucolytic NIFEDIPINE (21829-25-4), JDMF NIFUROXAZIDE (965-52-6) Antidiarrheal 2 Product List
Standard Package Regulatory Data Pharmacopoeias Production Site NITROSCANATE (19881-18-6) Anthelmintic 50 kg VMF BENECHIM OLANZAPINE (132539-06-1) Antipsychotic Fiber drum/kg OXANTEL PAMOATE (68813-55-8) Anthelmintic EVMF PANTOPRAZOLE SODIUM (138786-67-1) PYRANTEL EMBONATE (22204-24-6) Antiulcerative Anthelmintic EVMF USVMF Ph. Eur 7 PRILOCAINE HCL (1786-81-8) BENECHIM QUETIAPINE FUMARATE (111974-72-2) Antipsychotic & SERTRALINE HCL (79559-97-0) Antidepressant SOTALOL HCL (959-24-0) 30 Kg SUMATRIPTAN SUCCINATE BASE (103628-48-4) Antimigraine Fiber drum/kg,, JDMF TRIAMTERENE (396-01-0) TRIMEBUTINE MALEATE (34140-59-5) Diuretic Antispasmodic 35 Kg, JDMF JP 15 VENLAFAXINE HCL (99300-78-4) Antidepressant 3 Product List
Availability Regulatory Data Pharmacopoeias DRONEDARONE (**) (141626-36-0) TP DULOXETINE HCL (**) (136434-34-9) Antidepressant ENTACAPONE (**) (130929-57-6) Antiparkinsonian IRBESARTAN (138402-11-6) OLMESARTAN (**) (144689-63-4) Angiotensin II antagonist PREGABALIN (**) (148553-50-8) Antiepileptic RABEPRAZOLE SODIUM (**) (117976-90-6) Anti ulcerative TELMISARTAN (**) (144701-48-4) (**) Products covered by valid patents are being developed under experimental aims in base of Art. 10(6) of Directive 2004/27/EC, exclusively directed to obtain market authorizations of our customers generic medicines. Samples for R&D use in the United States are available as permitted under 35 USC 271 (e) (1). Products covered by valid patents in any country are not offered or supplied to these countries when such offer constitutes a patent infringement. 4 Product List
Additional Information DMF / TP EZETIMIBE (**) (163222-33-1) Lipid modifying agent TP PRASUGREL (**) (150322-43-3) Anticlotting agent Batches SITAGLIPTIN (**) (144689-63-4) Antidiabetic TP VILDAGLIPTIN (**) (274901-16-5) Antidiabetic Batches (**) Products covered by valid patents are being developed under experimental aims in base of Art. 10(6) of Directive 2004/27/EC, exclusively directed to obtain market authorizations of our customers generic medicines. Samples for R&D use in the United States are available as permitted under 35 USC 271 (e) (1). Products covered by valid patents in any country are not offered or supplied to these countries when such offer constitutes a patent infringement. 5 Product List
Brand Name Galenic Form APIXABAN (**) (503612-47-3) Eliquis Antibleeding agent 2.5mg Tablet DABIGATRAN (**) (211914-51-1) Pradaxa Anticlotting agent 75mg, 110mg, 150 mg Capsule DAPOXETINE (**) (129938-20-1) Priligy Anti-premature ejaculation agent 30mg, 60mg Tablet DEFERASIROX (**) (201530-41-8) Exjade Iron Chelator 125mg, 250mg, 500mg Tablet FINGOLIMOD (**) (162359-56-0) Gilenya Inmunomodulating Agent 0.5mg Capsule RIVAROXABAN (**) (366789-02-8) Xarelto Antibleeding agent 10mg, 15mg, 20mg Tablet SILODOSIN (**) (160970-54-7) Urief Antagonist for the treatment of Benign Prostatic Hyperplasia 4mg, 8mg Capsule TICAGRELOR (**) (274693-27-5) Brilinta Platelet aggregation inhibitor 90mg Tablet (**) Products covered by valid patents are being evaluated to be developed under experimental aims in base of Art. 10(6) of Directive 2004/27/EC, exclusively directed to obtain market authorizations of our customers generic medicines. Samples for R&D use in the United States will be available as permitted under 35 USC 271 (e) (1). Products covered by valid patents in any country will not be offered or supplied to these countries when such offer constitutes a patent infringement. 6 Product List